A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

NCT02020889 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Churg-Strauss Syndrome

Interventions

BIOLOGICAL: Mepolizumab
DRUG: Placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]